𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis of the major metabolites of Paroxetine

✍ Scribed by Mireia Segura; Lidia Roura; Rafael de la Torre; Jesús Joglar

Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
144 KB
Volume
31
Category
Article
ISSN
0045-2068

No coin nor oath required. For personal study only.

✦ Synopsis

Paroxetine is a well-known antidepressant, used worldwide in therapeutics. In comparison with other selective serotonin reuptake inhibitors, it exhibits the highest activity in serotonin reuptake inhibition. Paroxetine metabolism initially involves its demethylenation to the catechol intermediate, which is then O-methylated at positions C3 or C4. Herein, the chemistry resulting in the syntheses of these metabolites (3S,4R)-4-(4-fluorophenyl)-3-(hydroxymethyl)piperidine and (3S,4R)-4-(4-fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine is described starting from the common intermediate (3S,4R)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine. Additionally, the common intermediate was used to synthesize paroxetine, which had the same structure and stereochemistry as commercial paroxetine, thereby confirming our synthetic route.

📜 SIMILAR VOLUMES

Stereospecific synthesis of the major hu
Stereospecific synthesis of the major human metabolite of paclitaxel
✍ Mark D Wittman; John F Kadow; Dolatrai M Vyas 📂 Article 📅 2000 🏛 Elsevier Science 🌐 French ⚖ 124 KB

The stereospeci®c synthesis of 6-a-hydroxy paclitaxel 10, the major human metabolite of paclitaxel, is described. The 6,7-a-diol 4, obtained from paclitaxel, is converted to the 6,7-b-cyclic sulfate followed by nitrate addition and reduction to aord the title compound.

Synthesis of labeled ambroxol and its ma
Synthesis of labeled ambroxol and its major metabolites
✍ Bachir Latli; Matt Hrapchak; Heinz-Karl Switek; Daniel M. Retz; Dhileepkumar Kri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 253 KB

## Abstract Ambroxol is a mucolytic agent used in the treatment of respiratory diseases. Herein, we report the synthesis of carbon‐14‐labeled ambroxol with the radioactive atom(s) either on the benzylic carbon or uniformly in the cyclohexyl ring with specific activities of 59 and 81 mCi/mmol, respe

Controlled comparison of paroxetine and
Controlled comparison of paroxetine and fluvoxamine in major depression
✍ M. Ansseau; A. Gabriëls; J. Loyens; F. Bartholomé; J. L. Evrard; A. De Nayer; R. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

A multicentre study compared the antidepressant efficacy and the tolerance of two selective serotonin reuptake inhibitors, paroxetine (20-30 mg/d) and fluvoxamine (50-200 mg/d) in two parallel groups of respectively 56 and 64 patients with major depression, as defined by DSM-III-R criteria. The dura

A Convenient Synthesis of (-)-Paroxetine
A Convenient Synthesis of (-)-Paroxetine.
✍ Laszlo Czibula; Andras Nemes; Ferenc Seboek; Csaba Jr. Szantay; Marianna Mak 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 8 KB
A Convenient Synthesis of (−)-Paroxetine
A Convenient Synthesis of (−)-Paroxetine
✍ László Czibula; András Nemes; Ferenc Sebök; Csaba Szántay Jr.; Marianna Mák 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract A convenient synthesis of the antidepressant paroxetine starting from 1‐benzyl‐4‐piperidone (**2**) is reported. A stereoselective reduction resulted in __cis__‐piperidine‐3‐methanol [(**+**)‐**6**]. The reaction between __cis__‐piperidine‐3‐methanol mesylate (**7**) and sesamol led to

Isolation, identification, and synthesis
Isolation, identification, and synthesis of the major sulpiride metabolite in primates
✍ J. J. Brennan; A. R. Imondi; D. G. Westmoreland; M. J. Williamson 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

The major metabolite of sulpiride, N-[( 1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-2-anisamide (I), in the monkey is N-[(lethyl-5-oxo-2-pyrrolidinyl)methyl]-5-sulfamoyl-2-anisamide (11). It is also a metabolite in other laboratory animal species and possibly at very low levels in humans. Treatment o